Actiq Off-Label Marketing Suit Preempted, Pa. Panel Affirms
By Matt Fair ( May 10, 2018, 9:02 PM EDT) -- A Pennsylvania appeals court has refused to upend a trial judge's decision that federal law preempts claims that improper marketing of the Cephalon Inc. opiate painkiller "lollipop" Actiq led a plaintiff into addiction and death....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.